These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22983648)
1. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
3. Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Wang L; Wang WD; Xia ZJ; Zhang YJ; Xiang J; Lu Y Med Oncol; 2014 Mar; 31(3):860. PubMed ID: 24481637 [TBL] [Abstract][Full Text] [Related]
4. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma]. Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665 [TBL] [Abstract][Full Text] [Related]
6. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type. Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236 [TBL] [Abstract][Full Text] [Related]
7. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type. Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661 [TBL] [Abstract][Full Text] [Related]
8. Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study. Wang H; Wuxiao ZJ; Zhu J; Wang Z; Wang KF; Li S; Chen X; Lu Y; Xia ZJ Leuk Lymphoma; 2015 Apr; 56(4):971-7. PubMed ID: 24991715 [TBL] [Abstract][Full Text] [Related]
9. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma. Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536 [TBL] [Abstract][Full Text] [Related]
11. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy. Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma. Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948 [TBL] [Abstract][Full Text] [Related]
13. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma. Ma HH; Qian LT; Pan HF; Yang L; Zhang HY; Wang ZH; Ma J; Zhao YF; Gao J; Wu AD Med Oncol; 2010 Sep; 27(3):798-806. PubMed ID: 19685292 [TBL] [Abstract][Full Text] [Related]
15. Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers. Huang L; Yuan B; Wu H; Chu H; Liu Y; Wu S; Li H; Lu H; Chen H Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):152-158. PubMed ID: 28215935 [TBL] [Abstract][Full Text] [Related]
16. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type. Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803 [TBL] [Abstract][Full Text] [Related]
17. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275 [TBL] [Abstract][Full Text] [Related]
18. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]. Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799 [TBL] [Abstract][Full Text] [Related]
20. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]